Perrigo explores sale of royalties of drug Tysabri: sources
Go back to Perrigo explores sale of royalties of drug Tysabri: sources| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 221.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $221.07 | 52 Week High | $333.65 | |||
| Open | $221.07 | 52 Week Low | $223.02 | |||
| Day High | $221.07 | P/E | 28.31 | |||
| Day Low | $221.07 | EPS | $7.81 | |||
| Volume | 28 | |||||
| Mylan Inc. (NASDAQ: MYL) | Delayed: 15.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.86 | 52 Week High | $55.51 | |||
| Open | $10.56 | 52 Week Low | $33.60 | |||
| Day High | $15.86 | P/E | 10.43 | |||
| Day Low | $15.86 | EPS | $1.52 | |||
| Volume | 45,581 | |||||
| Perrigo (NYSE: PRGO) | Delayed: 14.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.76 | 52 Week High | $156.03 | |||
| Open | $14.76 | 52 Week Low | $79.72 | |||
| Day High | $14.76 | P/E | N/A | |||
| Day Low | $14.76 | EPS | $0.00 | |||
| Volume | 103 | |||||
